Corcept Therapeutics (CORT) Misses Q4 EPS by 10c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $113.63 -3.29%
EPS Growth %: +406.3%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +406.3%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q4 EPS of $0.14, $0.10 worse than the analyst estimate of $0.24. Revenue for the quarter came in at $103.1 million versus the consensus estimate of $105.08 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- General Mills beats estimates as cost savings offset volumes
- Corcept Announces Planned Leadership Transition
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
